-
1 Comment
electroCore, Inc is currently in a long term downtrend where the price is trading 42.3% below its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 22.5.
electroCore, Inc's total revenue sank by 99.5% to $3K since the same quarter in the previous year.
Its net income has increased by 100.0% to $-24 since the same quarter in the previous year.
Finally, its free cash flow grew by 66.3% to $-3M since the same quarter in the previous year.
Based on the above factors, electroCore, Inc gets an overall score of 3/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US28531P2020 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 49M |
---|---|
Beta | 0.84 |
PE Ratio | None |
Target Price | 25.2 |
Dividend Yield | None |
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ECOR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025